Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study Meeting Abstract
| Authors: | Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. |
| Abstract Title: | Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study |
| Meeting Title: | 51st Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 66 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Oct 23-26 |
| Meeting Location: | Lyon, France |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2019-12-01 |
| Start Page: | S33 |
| Language: | English |
| ACCESSION: | WOS:000488458000058 |
| PROVIDER: | wos |
| PUBMED: | 31568621 |
| DOI: | 10.1002/pbc.27989 |
| Notes: | Meeting Abstract: FP051 SIOP19-1468 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
